N/A N=28 Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft
Tooth Extraction Status Nos
Primary: Changes in Alveolar Bone (mm) — -1.47; -1.21 mm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=45 Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
Multiple Myeloma
Primary: Number of Participants With Serious and Non-serious Adverse Events — 45 Participants
N/A N=28 Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Breast Neoplasms
Primary: Skin Toxicity the First Year Following Treatment With the Multiple Dwell Mammosite Delivery Method. — 2; 0; 0; 0 Participants
N/A N=40 Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis
Diabetic Ketoacidosis
Primary: Time to Anion Gap Closure — 10.2; 11.6 hours
N/A N=253 RCT of Effects of Device-guided Breathing on Ambulatory BP
Hypertension
Primary: Change in Systolic and Diastolic BP Measured by Ambulatory BP Monitoring (Waking Averages) — 5.8; 6.6; 1.2; 4.0 mm Hg — p=.01
N/A N=30 Open Label Study Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions
Aging
Primary: Frontal Temporal Fossa Rating Scale — 10; 13; 7; 0 Participants
Phase 3 N=25 Study of Paliperidone ER in Adolescents and Young Adults With Autism
Autism
Primary: The Clinical Global Impression-Improvement(CGI-I) — 1.8 units on a scale
Phase 4 N=31 Ranolazine and Microvascular Angina by PET in the Emergency Department
Microvascular Angina
Primary: Coronary Flow Reserve — 1.6; 1.6; 1.9; 1.6 ratio
Phase 4 N=50 Short Term Rescue Study of Olanzapine
Bipolar Disorder
Primary: Mean Change in CGI-BP-OS After 1 Week of Treatment — -1.4; .8 units on a scale — p=.08
N/A N=20 A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin
Skin Disease
Primary: Expression Levels of Antimicrobial Peptides in Samples of Normal Appearing Skin and Skin Subjected to Occlusion With and Without Petrolatum. — 9.12; 7.025; 5.415; 8.926…
Phase 3 N=214 Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)
Osteoporosis
Primary: Percent Change From Baseline to Month 12 in Lumbar Spine Areal Bone Mineral Density (aBMD) — 3.63; 0.14 percent change — p=<0.001
Phase 4 N=70 Single-shot TAP Block vs Continuous TAP Block
Postoperative Pain
Primary: Total Narcotic Usage at 48 Hours — 2.44; 2.88 mg
N/A N=61 Percutaneous Rectus Sheath Block Versus Intra-operative Rectus Sheath Block for Pediatric Umbilical Hernia Repair
Pain, Postoperative
Primary: Post Operative Pain Rating — 2.6; 3.3 units on a scale — p=0.11
N/A N=1 Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)
Adenoid Cystic Carcinoma
Primary: Number of Participants With Disease Progression — 1 Participants
Phase 3 N=91 Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances
Acute Kidney Injury · Exercise-associated Hyponatremia · Perceived Exertion
Primary: Acute Kidney Injury — 16; 22 Participants